or
forgot password

    • cancer clinical trials in indianapolis, IN

    • VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
    St. Vincent Gynecologic Oncology
    Indianapolis, Indiana 46260
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    Study of BMS-936558 vs. Everolimus in Pre-Treated Advanced Or Metastatic Clear-cell RCC
    Local Institution
    Indianapolis, Indiana
    Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
    Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging
    Indiana University
    Indianapolis, Indiana 46202
    Endometrial Cancer, Cervical Cancer
    OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
    Indiana University Melvin and Bren Simon Cancer Center

    Trial Locations
    Indiana University Melvin and Bren Simon Cancer Center
    IU Health Central Indiana Cancer Centers
    Prostate Cancer, Metastatic Castrate-Resistant Prostate Cancer, PSA
    Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
    Dawes Fretzin Clinical Research Group, LLC
    Indianapolis, Indiana 46256
    Psoriasis, Psoriatic Arthritis
    SGI-110 in Combination With Carboplatin in Ovarian Cancer
    Melvin and Bren Simon Cancer Center- Indiana University
    Indianapolis, Indiana 46202
    Ovarian Cancer
    Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
    Franciscan St. Francis Health
    Indianapolis, Indiana 46237
    High Risk Acute Myeloid Leukemia
    Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery
    Indiana University Cancer Center
    Indianapolis, Indiana 46202-5265
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage III Salivary Gland Cancer, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage III Verrucous Carcinoma of the Larynx, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Oropharynx, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Cabozantinib in Treating Younger Patients With Recurrent or Refractory Solid Tumors
    Riley Hospital for Children
    Indianapolis, Indiana 46202
    Recurrent Melanoma, Recurrent Thyroid Cancer, Thyroid Gland Medullary Carcinoma, Unspecified Childhood Solid Tumor, Protocol Specific
    A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
    Indiana University Melvin and and Bren Simon Cancer Center
    Indianapolis, Indiana 46202
    Non-small Cell Lung Cancer(NSCLC)
    A Moderate to Severe Rheumatoid Arthritis Study
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Indianapolis, Indiana 46227
    Rheumatoid Arthritis
    FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer
    St. Vincent Health Group
    Indianapolis, Indiana 46260
    Colorectal Cancer Metastatic
    Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors
    Riley Hospital for Children
    Indianapolis, Indiana 46202
    Unspecified Childhood Solid Tumor, Protocol Specific
    Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL
    Indiana University
    Indianapolis, Indiana 46202
    Cutaneous T-Cell Lymphoma
    Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
    IU Health Methodist Hospital
    Indianapolis, Indiana 46202
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression
    Indiana University Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202-5289
    Bladder Cancer
    Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors
    Indiana University Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202-5289
    Chemotherapy-Induced Nausea and Vomiting
    Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas
    Indiana Unversity
    Indianapolis, Indiana 46202
    Neurofibromatosis Type 2, Progressive Vestibular Schwannomas
    Evaluation of a New EUS-guided Needle (ProCore) Comparing to EUS-TCB Needle (Quick-Core)
    Indiana University Hospital
    Indianapolis, Indiana 46202
    Gastrointestinal Tumors.
    Recombinant Human IL-18 and Ofatumumab After PBSCT for Lymphoma
    Indiana University Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202-5289
    Non-Hodgkin's Lymphoma
    Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
    IU Simon Cancer Center
    Indianapolis, Indiana 46202
    Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer
    Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer
    Indiana University Melvin & Bren Simon Cancer Center

    Trial Locations
    Indiana University Melvin & Bren Simon Cancer Center
    IU Health Central Indiana Cancer Centers
    Bladder Cancer, Urothelial Carcinoma
    A Twelve Week Safety and Efficacy Study in Rosacea
    Dawes Fretzin Clinical Research Group
    Indianapolis, Indiana 46256
    Papulopustular Rosacea
    Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
    Indiana University Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202-5289
    Breast Cancer, Obesity
    Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
    Franciscan St. Francis Health
    Indianapolis, Indiana 46237
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Patients' Opinions and Responses to the National Cancer Institute's Colorectal Cancer Risk Assessment Tool
    Indiana University Health
    Indianapolis, Indiana 46202
    Colorectal Cancer
    Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
    Indiana University Cancer Center
    Indianapolis, Indiana 46202-5265
    Adult Central Nervous System Germ Cell Tumor, Adult Teratoma, Malignant Extragonadal Germ Cell Tumor, Malignant Extragonadal Non-Seminomatous Germ Cell Tumor, Extragonadal Seminoma, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Ovarian Germ Cell Tumor, Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor, Stage IV Extragonadal Seminoma, Stage IV Ovarian Germ Cell Tumor
    Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma
    Indiana University Medical Center
    Indianapolis, Indiana 46202
    Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma, Stage II Malignant Mesothelioma, Stage III Malignant Mesothelioma, Stage IV Malignant Mesothelioma
    Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)
    St. Francis Medical Group Oncology & Hematology Specialists
    Indianapolis, Indiana 46237
    Carcinomas, Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin, Neoplasms
    An Extended Use Study of Safety and Efficacy of OncoVEXGM-CSF in Melanoma
    Indiana University
    Indianapolis, Indiana 46202
    Melanoma
    A Rollover Protocol for Subjects Previously Treated With AGS-003
    The Indiana University Cancer Center
    Indianapolis, Indiana 46202
    Renal Cell Carcinoma
    A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
    Indiana Univ. School of Medicine, Infectious Disease Research Clinic

    Trial Locations
    Indiana Univ. School of Medicine, Infectious Disease Research Clinic
    Methodist Hosp. of Indiana
    HIV Infections
    A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma
    Indiana Univ. School of Medicine, Infectious Disease Research Clinic
    Indianapolis, Indiana 46202
    Lymphoma, Non-Hodgkin, HIV Infections
    Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)
    Indiana Univ. School of Medicine, Infectious Disease Research Clinic
    Indianapolis, Indiana 46202
    Candidiasis, Mycoses, HIV Infections
    A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)
    Indiana Univ. School of Medicine, Infectious Disease Research Clinic
    Indianapolis, Indiana 46202
    Pneumonia, Pneumocystis Carinii, HIV Infections